The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ResMed Inc.’s RMD growth in the third quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its progress in digital health technology continues to drive overall ...
Resmed Inc. RMD continues to see strong demand for its market-leading mask portfolio, including AirFit, AirTouch and other ranges. The company often relies on strategic acquisitions to strengthen its ...
ResMed Inc.’s RMD robust performance of its Mask business is supported by continued product development within the portfolio. Its Software-as-a-Service (SaaS) business continues to benefit from ...
Hosted on MSN
RMD Q1 deep dive: Mask portfolio drives growth amid market uncertainty and new CFO appointment
Medical device company ResMed (NYSE:RMD) reported Q1 CY2026 results , with sales up 10.8% year on year to $1.43 billion. Its non-GAAP profit of $2.86 per share was 2.2% above analysts’ consensus ...
ResMed Inc. RMD has been gaining investors’ confidence on consistently positive results. Over the past year, the company’s shares have outperformed its industry. The stock has gained 38.3% during the ...
RMD benefits from acquisition-led Residential Care Software expansion and mask innovation. RMD Residential Care Software revenues rose 4% CC, driven by MEDIFOX DAN, Home & Hospice, HME. Mask sales in ...
Resmed RMD benefits from the acquisition-led expansion of its Residential Care Software segment, which is poised to continue supporting its growth in the coming quarters. The company continues to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results